BrainCheck
Category: AI in Healthcare
BrainCheck is a digital platform for cognitive assessment and care, helping providers detect and monitor cognitive decline like dementia and MCI. BrainCheck was founded in 2016. The company is led by Chris Loughlin. Based in Austin, Texas, United States. Team size: 101-500. Total funding raised: $34M. Latest round: Series A. Key investors include Next Coast Ventures, S3 Ventures, UPMC Enterprises.
- Founded
- 2016
- Headquarters
- Austin, Texas, United States
- Team size
- 101-500
- Total funding
- $34M
Value proposition
A comprehensive, data-backed digital cognitive toolset that integrates into clinical workflows to enable proactive screening, accurate baseline measurement, and personalized care planning for brain health.
Products and solutions
BrainCheck Assess (FDA Class II medical device for clinical cognitive evaluation), BrainCheck Screen, BrainCheck Plan (care planning), Population Analytics
Unique value
FDA-cleared, evidence-based digital cognitive assessment combined with AI-assisted population health analytics and seamless EHR workflow integration.
Target customer
Primary care providers, health systems, specialty clinics, and enterprise healthcare organizations (e.g. via EHR integration)
Industries served
Healthcare, Cognitive/Brain Health, Primary Care, Neurology, Senior Care
Technology advantage
FDA Class II clearance for BrainCheck Assess; AI-assisted longitudinal population health analytics; deep EHR integration reducing clinical workflow friction.
How they differentiate
FDA-cleared medical device status plus AI-driven longitudinal analytics and EHR-embedded workflow, vs. competitors focused on standalone digital cognitive tests.
Main competitors
Linus Health, Altoida, Cambridge Cognition
Key partnerships
Hint Health (direct primary care practices), UPMC Enterprises (investor/strategic partner), EHR system integrations
Notable customers
Bon Secours, UPMC, UPMC Family Medicine and Geriatrics, Springfield Clinic, Weill Cornell-affiliated practices, Victory Medical, University of Colorado Anschutz Medical Campus, The University of Texas at Austin, Stanford University
Major milestones
2016: Founded / $3M seed round, 2019: $8M Series A, 2021: $10M raise (total ~$21M), Oct 2024: Chris Loughlin becomes CEO, Jul 2025: Steve Wardle joins as President, Feb 2026: $13M raise (total ~$34M) to expand AI-enabled enterprise cognitive care infrastructure.
Market positioning
Leading enterprise-grade digital cognitive assessment and care platform for health systems and primary care networks.
Geographic focus
United States (national), expanding NYC office
About Chris Loughlin
Ex-CEO at Digital Pharmacist (2016-2020, scaled to 7,500+ pharmacies / $20M+ ARR); Ex-Managing Partner at Pixiu Investments (private equity, Austin TX, 2020-2024); Ex-CEO at Travelzoo (NASDAQ: TZOO) for 5.5 years, grew revenue to $160M+, plus prior senior roles there from 2001.
Latest news about BrainCheck
More AI in Healthcare companies
Official website: https://braincheck.com